NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) has announced a funding opportunity for the NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional), aimed at fostering strong international research collaborations. This initiative requires applications to include at least one international subproject that leverages unique resources or expertise from foreign partners, while domestic prime organizations will manage the overall project. This funding opportunity is crucial for advancing health sciences by enabling innovative research that utilizes international talent and resources not readily available in the United States. Interested applicants must submit their proposals by May 7, 2029, and can direct inquiries to the NIH Office of Policy for Extramural Research Administration at operasystemspolicy@mail.nih.gov.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.One or more International Project is required.This funding opportunity is specifically designed to support funded international collaborations between a domestic prime organization and foreign organizations. This NOFO should not be used for projects in which the only international elements are foreign consultants, purchasing unique equipment or supplies from foreign vendors, foreign collaborations that do not involve NIH funding or any other foreign component that would not result in a foreign subaward.